BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 27027841)

  • 1. Role of tissue factor expression in thrombin generation by canine tumor cells.
    Gruber EJ; Catalfamo JL; Stokol T
    Am J Vet Res; 2016 Apr; 77(4):404-12. PubMed ID: 27027841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of procoagulant tissue factor expression in canine hemangiosarcoma cell lines.
    Witter LE; Gruber EJ; Lean FZ; Stokol T
    Am J Vet Res; 2017 Jan; 78(1):69-79. PubMed ID: 28029283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of coagulation factors and tissue factor concentration on the thrombin generation test in plasma.
    Duchemin J; Pan-Petesch B; Arnaud B; Blouch MT; Abgrall JF
    Thromb Haemost; 2008 Apr; 99(4):767-73. PubMed ID: 18392335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of tissue factor expression in canine tumor cells.
    Stokol T; Daddona JL; Mubayed LS; Trimpert J; Kang S
    Am J Vet Res; 2011 Aug; 72(8):1097-106. PubMed ID: 21801068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-1 proteinase inhibitor M358R reduces thrombin generation when displayed on the surface of cells expressing tissue factor.
    Gierczak RF; Pepler L; Bhagirath V; Liaw PC; Sheffield WP
    Thromb Res; 2014 Nov; 134(5):1142-9. PubMed ID: 25242242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the thrombin generation potential of leukemic and solid tumor cells by calibrated automated thrombography.
    Marchetti M; Diani E; ten Cate H; Falanga A
    Haematologica; 2012 Aug; 97(8):1173-80. PubMed ID: 22419573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue factor over-expression by human pancreatic cancer cells BXPC3 is related to higher prothrombotic potential as compared to breast cancer cells MCF7.
    Gerotziafas GT; Galea V; Mbemba E; Khaterchi A; Sassi M; Baccouche H; Prengel C; van Dreden P; Hatmi M; Bernaudin JF; Elalamy I
    Thromb Res; 2012 Jun; 129(6):779-86. PubMed ID: 21917301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue factor procoagulant activity in the tumor cell lines and plasma of dogs with various malignant tumors.
    Kobayashi K; Baba K; Igase M; Primarizky H; Nemoto Y; Shimokawa Miyama T; Kambayashi S; Mizuno T; Okuda M
    J Vet Med Sci; 2019 Dec; 81(12):1713-1721. PubMed ID: 31611484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation and characterization of a monoclonal antibody against canine tissue factor.
    Stokol T; Daddona J; DeLeonardis C; Dong L; Wagner B
    Vet Immunol Immunopathol; 2015 Oct; 167(3-4):178-84. PubMed ID: 26187440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differing mechanisms of thrombin generation in live haematological and solid cancer cells determined by calibrated automated thrombography.
    Adesanya MA; Maraveyas A; Madden L
    Blood Coagul Fibrinolysis; 2017 Dec; 28(8):602-611. PubMed ID: 28692431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated coagulation factor levels affect the tissue factor-threshold in thrombin generation.
    Rietveld IM; Schreuder M; Reitsma PH; Bos MHA
    Thromb Res; 2018 Dec; 172():104-109. PubMed ID: 30408635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer.
    Haubold K; Rink M; Spath B; Friedrich M; Chun FK; Marx G; Amirkhosravi A; Francis JL; Bokemeyer C; Eifrig B; Langer F
    Thromb Haemost; 2009 Jun; 101(6):1147-55. PubMed ID: 19492160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the initiation phase of blood coagulation using ultrasensitive assays for serine proteases.
    Butenas S; van 't Veer C; Mann KG
    J Biol Chem; 1997 Aug; 272(34):21527-33. PubMed ID: 9261172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of tissue factor, thrombomodulin and elevated clotting factor levels on thrombin generation in the calibrated automated thrombogram.
    Machlus KR; Colby EA; Wu JR; Koch GG; Key NS; Wolberg AS
    Thromb Haemost; 2009 Nov; 102(5):936-44. PubMed ID: 19888532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring thrombin generation: is addition of corn trypsin inhibitor needed?
    Spronk HM; Dielis AW; Panova-Noeva M; van Oerle R; Govers-Riemslag JW; Hamulyák K; Falanga A; Cate HT
    Thromb Haemost; 2009 Jun; 101(6):1156-62. PubMed ID: 19492161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin generation in plasma of healthy adults and children: chromogenic versus fluorogenic thrombogram analysis.
    Devreese K; Wijns W; Combes I; Van kerckhoven S; Hoylaerts MF
    Thromb Haemost; 2007 Sep; 98(3):600-13. PubMed ID: 17849049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systems biology of coagulation initiation: kinetics of thrombin generation in resting and activated human blood.
    Chatterjee MS; Denney WS; Jing H; Diamond SL
    PLoS Comput Biol; 2010 Sep; 6(9):. PubMed ID: 20941387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monocyte IL-10 produced in response to lipopolysaccharide modulates thrombin generation by inhibiting tissue factor expression and release of active tissue factor-bound microparticles.
    Poitevin S; Cochery-Nouvellon E; Dupont A; Nguyen P
    Thromb Haemost; 2007 Apr; 97(4):598-607. PubMed ID: 17393023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII.
    Nielsen VG; Cohen BM; Cohen E
    Acta Anaesthesiol Scand; 2005 Feb; 49(2):222-31. PubMed ID: 15715625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anticoagulant mechanism of action of recombinant hirudin (CGP 39393) in plasma.
    Lindhout T; Blezer R; Hemker HC
    Thromb Haemost; 1990 Nov; 64(3):464-8. PubMed ID: 2096492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.